Kedrion Biopharma, Inc.

Kedrion Biopharma, Inc.
Kedrion SpA (“Kedrion”) is an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing serious diseases, disorders and conditions such as hemophilia, Primary Immune Deficiency and Rh sensitization which can lead to hemolytic disease of the fetus and newborn.

Kedrion Biopharma Inc. (“Kedrion Biopharma”), the US subsidiary of Kedrion, is headquartered in Fort Lee, New Jersey.

Kedrion Biopharma launched US operations in 2011, but the company’s international roots stretch back several decades in the production of blood and plasma-derived products. It places a high value not only on the welfare of those who benefit from its products but also on the people and communities it serves.
http://www.kedrion.us/
(201) 242-8900
400 Kelby Street, 11th Floor
Fort Lee, NJ 07024
http://www.sci.bio/job-search/

Send Message to listing owner

Kedrion Biopharma, Inc.